Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
1996
DOI: 10.1002/(sici)1097-4547(19960815)45:4<475::aid-jnr18>3.0.co;2-#
|View full text |Cite
|
Sign up to set email alerts
|

Neonatal injection of Lewis rats with recombinant Vβ8.2 induces T cell but not B cell tolerance and increased severity of experimental autoimmune encephalomyelitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
8
0

Year Published

1997
1997
2008
2008

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(8 citation statements)
references
References 20 publications
0
8
0
Order By: Relevance
“…TCR peptides derived mostly from the conserved complementarity determining region (CDR) and framework (Fr) regions of the TCR V β -chains have been found to be immunogenic in both animals and in humans (23)(24)(25)(26)(27)(28)(29)(30)(31)(32)(33)(34)(35). Although the phenotype or the MHC restriction of Tregs has not been defined in most cases, it is clear that peptides from 2 distinct conserved regions, namely the Fr3 and CDR1/2 regions on the TCR V β 8.2 chain, can induce regulation and protection from antigen-induced EAE in both rats and B10.PL mice (15,26,27,29,30,(36)(37)(38)(39)(40).…”
Section: Specificity For Regulation Is Provided By the Recognition Ofmentioning
confidence: 98%
See 1 more Smart Citation
“…TCR peptides derived mostly from the conserved complementarity determining region (CDR) and framework (Fr) regions of the TCR V β -chains have been found to be immunogenic in both animals and in humans (23)(24)(25)(26)(27)(28)(29)(30)(31)(32)(33)(34)(35). Although the phenotype or the MHC restriction of Tregs has not been defined in most cases, it is clear that peptides from 2 distinct conserved regions, namely the Fr3 and CDR1/2 regions on the TCR V β 8.2 chain, can induce regulation and protection from antigen-induced EAE in both rats and B10.PL mice (15,26,27,29,30,(36)(37)(38)(39)(40).…”
Section: Specificity For Regulation Is Provided By the Recognition Ofmentioning
confidence: 98%
“…Although the phenotype or the MHC restriction of Tregs has not been defined in most cases, it is clear that peptides from 2 distinct conserved regions, namely the Fr3 and CDR1/2 regions on the TCR V β 8.2 chain, can induce regulation and protection from antigen-induced EAE in both rats and B10.PL mice (15,26,27,29,30,(36)(37)(38)(39)(40). It is noteworthy that in humans, both the CDR2 and Fr3 regions have been found to be immunogenic and can potentially induce Treg activity (34,35,41).…”
Section: Specificity For Regulation Is Provided By the Recognition Ofmentioning
confidence: 99%
“…Ags: N-acetylated MBP 1-11 peptide (Ac-ASQKRPSQRSK) was synthesized by solid phase techniques and was purified by HPLC at the Beckman Institute, Stanford University (Stanford, CA). GST-BV8S2 proteins were expressed and purified as described previously (24). The GST-BV8S2 fusion protein contains the complete BV, BD, and BJ regions and the first 19 residues of the BC region from the TCR of an encephalitogenic rat T cell clone fused to the C-terminal end of GST.…”
Section: Micementioning
confidence: 99%
“…Several investigations have suggested the induction of TCRpeptide-reactive T cells following vaccination with pathogenic T cell lines, clones or peptides derived from the TCR expressed on pathogenic T cells (11, 14 -20). Importantly, the Fr3 region of the TCR V␤8.2 chain has been shown to contain an immunodominant determinant in mouse, rat and human models (11,12,(21)(22)(23)(24). Furthermore, the T cell repertoire reactive to this region cannot be tolerized by neonatal or i.v.…”
mentioning
confidence: 99%
“…Furthermore, the T cell repertoire reactive to this region cannot be tolerized by neonatal or i.v. tolerance-inducing protocols in either mice or rats (11,13,23). We and others have used different approaches to induce efficient expansion of TCR-peptide-reactive regulatory T cells in the hope of identifying the optimal protocol for the modulation of autoimmunity.…”
mentioning
confidence: 99%